All In Biotech

Drug Trial Radar · NCT04154293

A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis

A Randomized, Parallel, Double-Blind, Vehicle Controlled Study to Evaluate the Safety and Efficacy of Two Concentrations of Topical TMB-001 for the Treatment of Congenital Ichthyosis

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

34

Actual

Start

Dec 3, 2019

Primary completion

Aug 20, 2021

Study completion Aug 30, 2021

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
First posted
Nov 6, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 9 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the efficacy and safety of two concentrations of topically applied ointment formulation of isotretinoin called TMB-001 (0.05% and 0.1% isotretinoin) in subjects 9 years of age and older for the treatment of congenital ichthyosis (CI), including recessive X-linked ichthyosis (RXLI) and autosomal recessive congenital ichthyosis-lamellar ichthyosis (ARCI-LI) subtypes. Funding Source FDA-OOPD

Conditions

  • Congenital Ichthyosis

Interventions

  • IsotretinoinDrug

    Topical Isotretinoin ointment

  • VehicleOther

    Topical Vehicle Ointment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Reduction in Targeted Ichthyosis Severity Using the Visual Index for Ichthyosis Severity MeasurementTime frame: 12 weeks

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Medical Dermatology Specialists

    Phoenix, Arizona

  • Stanford University School of Medicine

    Palo Alto, California

  • Yale Center for Clinical Investigation

    New Haven, Connecticut

  • The Indiana Clinical Trials Center

    Plainfield, Indiana

  • Austin Institute for Clinical Research, Inc

    Metairie, Louisiana

  • Minnesota Clinical Study Center

    New Brighton, Minnesota

  • Cincinnati Children's Hospital

    Cincinnati, Ohio

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Queensland Children's Hospital

    Brisbane, Queensland, Australia

  • Premier Specialists, The church

    Kogarah, Sydney, Australia

  • Murdoch Children's Research Institute, RCH

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.